← All diseases
Liver, kidneys and digestion
Liver cirrhosis
Would you like to receive a message when there is new research about Liver cirrhosis? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, one sentence above each publication explains what was studied — and you'll be notified as soon as new research on Liver cirrhosis is available. View what Premium costs.
Publications and studies (3112)
- Sarcopenia in decompensated cirrhosis: a comparative analysis of bioelectrical impedance-based measures. (2026/07/28) ♡
- Protocol for OPAL: Online prehabilitation for patients with cirrhosis awaiting liver transplantation - A multicentre randomized controlled trial. (2026/07/28) ♡
- Machine learning prediction of complications after surgery in cirrhotic patients: Integrating nutritional risk with liver function. (2026/07/27) ♡
- A hepatic enigma: Pediatric presentation of primary biliary cholangitis. (2026/07/27) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Global multicenter validation of noninvasive fibrosis assessment pathways in MetALD and ALD. (2026/07/27) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Oncological and perioperative outcomes in minimally invasive hepatobiliary surgery: A review for the ESSO core curriculum. (2026/07/25) ♡
- Obacunone attenuates Cholestatic liver disease via PPARα activation and gut microbiota remodeling. (2026/07/25) ♡
- Comparative Outcomes of Rifaximin Monotherapy and Lactulose in Cirrhosis: A Multicenter Cohort Study. (2026/07/24) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Fibrosis regression in chronic liver disease: the pathologist's view. (2026/07/24) ♡
- Prospective validation of imaging and serum diagnostic biomarkers of steatohepatitis and fibrosis in MASLD: the LITMUS Imaging Study. (2026/07/24) ♡
- Inflammation-metabolism composite (CRP-triglyceride-glucose index) predicts all-cause and cardiovascular mortality in MASLD with advanced fibrosis: Evidence from a national NHANES cohort. (2026/07/24) ♡
- Bupleuri radix total saikosaponins alleviate liver fibrosis by inhibiting hepatic stellate cell activation via SIRT3-SMAD3/HIF-1α -mediated glycolysis. (2026/07/24) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Exercise and cold exposure as dual physiological stressors in MASLD: AMPK-mediated metabolic adaptation and interorgan crosstalk. (2026/07/24) ♡
- Rural-Urban Disparities in Heart Failure and Liver Cirrhosis Hospitalizations: A National Inpatient Sample Database Analysis (2016-2022). (2026/07/24) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The new era of MASH pharmacotherapy: a comprehensive review of FDA-approved and emerging agents. (2026/07/23) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Hepatic granulomas as a manifestation of ANCA-associated vasculitis: a systematic review. (2026/07/23) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Supra-hepatic gallbladder in cirrhosis presenting as a mimic of intra-abdominal fat necrosis: Diagnostic pitfalls and clinical implications. (2026/07/23) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Beyond cardiovascular protection: a conceptual and translational review of the hepato-specific mechanisms of statins in metabolic dysfunction-associated steatotic liver disease (MASLD). (2026/07/23) ♡
- A Simplified non-invasive model based on albumin, bilirubin, and platelet count for predicting high-risk varices in compensated cirrhosis. (2026/07/23) ♡
- Plasma metabolic signatures of healthy dietary patterns and risk of metabolic dysfunction-associated steatotic liver disease and cirrhosis. (2026/07/22) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Prior decompensation Identifies Patients at High Mortality Risk Despite Standard Therapy After Variceal Hemorrhage: An IPD Meta-analysis. (2026/07/22) ♡
- AI digital pathology as a key tool providing in-depth understanding of the progression and regression of MASH and fibrosis in male mouse models. (2026/07/22) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Circulating Adipokines in Alcohol-Related Liver Disease and MetALD: A Systematic Review and Structured Narrative Synthesis. (2026/07/22) ♡
- Multimodal OCT Biomarkers of Fibrosis and Steatosis in the Regenerating Liver. (2026/07/22) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Microbiota in cholestatic diseases: crosstalk among bile composition, the biliary microbiome, and host immunity. (2026/07/22) ♡
- Obesity phenotypes, omics signatures, and risk of adverse liver outcomes. (2026/07/21) ♡
- [APASL clinical practice guidelines on the management of chronic hepatitis B infection: a 2026 update]. (2026/07/20) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. The value of mNGS in the diagnosis of central nervous system infections in immunodeficient hosts with decompensated cirrhosis complicated by Listeria encephalitis: Case Report. (2026/07/20) ♡
- CCL20-CCR6 axis mediates mucosal-associated invariant T-M2 macrophage crosstalk to drive immune dysregulation in liver cirrhosis. (2026/07/20) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. The efficacy of traditional Chinese medicine on immune function in patients with hepatitis B-related liver fibrosis or cirrhosis: a systematic review and meta-analysis. (2026/07/20) ♡
- Lasso Regression-based Model for Cross-Sectional Identification of Significant Hepatic Fibrosis in NAFLD LASSO-based identification of hepatic fibrosis in NAFLD. (2026/07/20) ♡
- Associations between Heavy Metals and Metalloids and Hepatic Fibrosis Risk in Chinese Adults: A Potential Modifying Effect of Thyroid Hormones. (2026/07/20) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Evaluating the Hepatoprotective Effect of Phyllanthus emblica and Panax ginseng Powders on Acetaminophen-Induced Liver Fibrosis in a Rat Model. (2026/07/19) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Pharmacological treatment of MASH. (2026/07/17) ♡
- Chronotype and FibroScan-Derived Liver Markers in Adults with Obesity: Preliminary Evidence from a Cross-Sectional Study. (2026/07/16) ♡
- The effects of a diet based on vegetable and dairy protein on nutritional status and MELD score in patients with liver cirrhosis: a randomized controlled study. (2026/07/15) ♡
- Vitamin D supplementation is associated with reduced risk of hepatobiliary malignancy in patients with primary sclerosing cholangitis. (2026/07/15) ♡
- Circulating multi-omic signature of disease severity and cholangiocarcinoma in primary sclerosing cholangitis. (2026/07/15) ♡
- Prospective validation of a real-time natural language processing pipeline for the extraction of elastography results from electronic health record data. (2026/07/15) ♡
- Biopsy-Proven Intestinal Failure-Associated Liver Disease in Pediatric Short Bowel Syndrome: Histopathological Findings and Clinical Outcomes. (2026/07/15) ♡
- Characteristics and outcomes of patients with imaging-defined MASLD and histological steatosis grade S0. (2026/07/14) ♡
- Hepatocyte CD146 and soluble CD146 promote hepatic stellate cell activation via the integrin αvβ1-p38 MAPK signaling axis to drive liver fibrosis. (2026/07/11) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Epidemiology of Alcohol-Associated Hepatitis: A Systematic Review of Population-Based Studies. (2026/07/11) ♡
- Association of fat-related metabolic indices with MASLD and liver fibrosis: a cross-sectional analysis of NHANES 2017-2020. (2026/07/10) ♡
- Dietary Guidelines 2025-2030 For Americans Are Concerning For Liver Health. (2026/07/09) ♡
- Association of the Model for End-Stage Liver Disease (MELD) Score With Spontaneous Bacterial Peritonitis in Patients With Liver Cirrhosis. (2026/07/07) ♡
- Mortality, cardiovascular, and hepatic decompensation outcomes of bempedoic acid in patients with cirrhosis: A multi-institutional study. (2026/07/06) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Transcriptomic Profiling Reveals Inflammatory, Fibrotic, and Apoptotic Signatures in a Methionine-Choline-Deficient Diet-Induced Murine Model of Metabolism-Dysfunction-Associated Steatohepatitis. (2026/07/05) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Hyponatremia as a Prognostic Marker in Cirrhosis: A Systematic Review of Its Role Beyond the Model for End-Stage Liver Disease in Predicting Mortality. (2026/07/04) ♡
- Association of high-sensitivity troponin with advanced fibrosis in metabolic dysfunction-associated steatotic liver disease and the potential mediating role of inflammation: A cross-sectional study of NHANES, 1999 to 2004. (2026/07/03) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.